comparemela.com

The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of market exclusivity.

Related Keywords

Chris Schott ,Eliav Barr ,Acceleron Pharma ,Drug Administration On ,Drug Administration ,Chief Medical Officer Eliav Barr ,Business ,Biotechnology ,Biotech And Pharmaceuticals ,Pharmaceuticals ,Health Care Industry ,Merck Amp Co Inc ,Science ,Breaking News ,Fda ,Business News ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.